General aspects of COVID-19 in pregnant and newborn health: A brief review

Authors

DOI:

https://doi.org/10.33448/rsd-v9i7.4969

Keywords:

Coronavirus; Pregnancy; Public health.

Abstract

The SARS-CoV-2 infection started in Wuhan / China in December 2019, spreading rapidly across Europe, the United States and Latin America, becoming a pandemic. COVID-19 is an acute disease with symptoms similar to those of a cold and can evolve to symptoms similar to severe pneumonia, its transmission happens through close contact, through droplets of saliva or particles that contain the virus. The present work aims to carry out an integrative literature review containing the main information about the impact of COVID-19 on the health of newborns and pregnant women. In order to develop it, a narrative review of the scientific literature was carried out, through an electronic search in the MEDLINE, SciELO, PubMed and LILACS databases. The WHO has advocated social isolation, however prenatal care should not be suspended during the pandemic period, noting the importance of taking care of yourself and the baby during pregnancy. Preventive measures, especially hygiene, must be adopted during all baby care. Some studies suggest that SARS-CoV-2 transmission from mother to child during pregnancy is unlikely, but that after birth, a newborn can become infected when exposed to an infected person. In addition, there have been some reported adversities, such as premature birth in babies born to mothers who tested positive for SARS-CoV-2. It can be concluded that more studies are needed to elucidate the characteristics of Sars-Cov-2 infection, especially in newborns, while the ideal is to maintain confidence in science and follow the recommendations recommended by WHO.

References

ACFB. (2020). Academia de Ciências Farmacêuticas do Brasil. As bases científicas do uso da cloroquina e da hidroxicloroquina sobre covid-19. Acesso em 31 de março de 2020. Disponível em: http:// cienciasfarmaceuticas.org.br/notice/acfb-informativoas-bases-cientificas-do-uso-da-cloroquina-e-da-hidro xicloquina-sobre-a-covid_19/.

Brasil. (2020). Ministério da Saúde. Secretaria de Políticas de Saúde. Corona vírus (COVID-19). Brasília, DF.

Cespedes MS & Souza JCRP (2020). Coronavirus: a clinical update of Covid-19. Revista da Associação Médica Brasileira, 66(2): 116-23.

Chan, JF et al. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. Lancet, 395:514–23.

Chen, H et al. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 395(10226):809–815.

Conselho Nacional de Saúde. (2020). Recomendação Nº 042, de 22 de maio de 2020. Acesso em: 26 maio 2020. Disponível em: http://conselho.saude.gov.br/recomendacoes-cns/1193-recomendacao-n-042-de-22-de-maio-de-2020.

Da Silva AAM (2020). On the possibility of interrupting the coronavirus (COVID-19) epidemic based on the best available scientific evidence. Revista Brasileira de Epidemiologia, 23:1–3.

Dong L, et al. (2020) Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA - Journal of the American Medical Association: E1–E3.

Duran P, et al. (2020). COVID-19 and newborn health: systematic review. Revista Panamericana de Salud Pública, 44(54).

Fox A, et al. (2020). Evidence of a significant secretory-IgA-dominant SARS-CoV-2 immune response in human milk following recovery from COVID-19. medRxiv.

Fu Y, et al. (2020). Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin.

Hon KLE, et al. (2003). Clinical presentations and outcome of severe acute respiratory syndrome in children. The Lancet, 361(9370):1701-1703.

Huang C, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395:497–506.

Lai, CC et al. (2020). Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. Journal of Microbiology, Immunology and Infection.

Lai CC et al. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19): The Epidemic and the Challenges. International Journal of Antimicrobial Agents, 55(3).

Liu W, et al. (2020). Clinical characteristics of 19 neonates born to mothers with COVID-19. Frontiers of Medicine, 1-6.

McIntosh, K. (2020). Novel Coronavirus (2019-nCov). UpToDat.

Mehta P, et al. (2020). On Behalf Of The Hlh Across Speciality Collaboration, Uk. Covid-19: consider cytokine storm syndromes and immunosuppression. International Health Regulations, 395:1033-1034.

Observatório Plataforma Brasil. (2020). Edição Especial Coronavirus (COVID-19). Relatório Semanal 02. Boletim Ética em Pesquisa.

Oliveira EHA (2020). Coronavírus: Prospecção científica e tecnológica dos fármacos em estudo para tratamento da Covid-19. Cadernos de Prospecção – Salvador, edição especial, 13(2):412-423.

OMS – Organização Mundial De Saúde. (2020). Acesso em: 15 mar. 2020. Disponível em: https://www.who.int/ith/ diseases/sars/en/; https://www.who.int/emergencies/mers-cov/en/.

Peng Z, et al. (2020). Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report. Journal of Infection and Public Health, 13(5).

Pereira, AS, Shitsuka, DM, Parreira, FJ & Shitsuka, R. (2018). Metodologia da pesquisa científica. [e-book]. Santa Maria. Ed. UAB/NTE/UFSM. Disponível em: https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa -Cientifica.pdf?sequence=1.

Quintella C, et al. (2020). Vacinas para Coronavírus (COVID-19; SARS-COV-2): mapeamento preliminar de artigos, patentes, testes clínicos e mercado. Cadernos de Prospecção, 13(1).

Rasmussen AS, et al. (2020). Doença de coronavírus 2019 (COVID-19) e gravidez: o que os obstetras precisam saber. Revista Americana de Obstetrícia e Ginecologia, 222(5):415-426.

Riccardo D (2020). Breast feeding at the time of COVID-19: do not forget expressed mother’s milk, please. Archives of Disease in Childhood-Fetal and Neonatal Edition.

Rondelli GPH, et al. (2020). Assistência às gestantes e recém-nascidos no contexto da infecção COVID-19: Uma revisão sistemática. Desafios - Revista Interdisciplinar da Universidade Federal do Tocantins. 7(3): 48-74.

Rose DMU, et al. (2020). Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far. Italian Journal of Pediatrics. 46(1):1-8.

Savarino A, et al. (2020). Effects of chloroquine on viral infections: an old drug against today’s diseases. The Lancet Infectious Diseases. 2003;3(11):722-727.

Schwartz DA. & Graham AL (2020). Potential maternal and infant outcomes from coronavirus 2019- NCOV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses, 12(2):1-16.

Sonja AR & Jamieson DJ (2020). Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation. Obstetrics and Gynecology.

Suárez-Mutis MC & Martínez-Espinosa FE (2020). Nota Técnica- Orientações sobre o uso da Cloroquina para tratamento de pacientes infectados com SARS-CoV-2, agente etiológico da Covid-19. Instituto Oswaldo Cruz. Acesso em: 24 de maio de 2020. Disponível em:<https://portal.fiocruz.br/sites/portal.fiocruz.br/files/documentos/orientacoes_sobre_a_cloroquina_nota_tecnica_.pdf>.

Tezer H & Demirdag TB (2020). Novel coronavirus disease (COVID-19) in children. Turkish Journal of Medical Sciences. 50(SI-1):592-603.

Van-Doremalen N, et al. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16):1564-1567.

Vilelas JMS (2020). O novo coronavírus e o risco para a saúde das crianças. Revista Latino-Americana de Enfermagem, 28.

Villela DAM (2020). The value of mitigating epidemic peaks of COVID-19 for more effective public health responses. Revista da Sociedade Brasileira de Medicina Tropical, 53(4):20200135.

Wang M, et al. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research,30: 269-271.

Wang L, et al. (2020). Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition). Annals of Translational Medicine, 8(3):1-8.

World Health Organization-WHO. (2020). Coronavirus disease 2019 (COVID-19) situation report - 72. 1 abril, 2020. Acesso em: 12 de maio de 2020. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/331685/nCoVsitrep01Apr2020-eng.pdf.

Yang P, et al. (2020). Clinical characteristics and risk assessment of newborns born to mothers with COVID-19. Journal of Clinical Virology, 127.

Zhao Z, et al. (2020). Prediction of the COVID-19 spread in African countries and implications for prevention and controls: A case study in South Africa, Egypt, Algeria, Nigeria, Senegal and Kenya. Science of The Total Environment, 729.

Zhou M, et al. (2020). Coronavirus disease 2019 (COVID-19): a clinical update. Frontiers of medicine:1-10.

Zhu H, et al. (2020). Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational Pediatrics, 9(1): 51-60.

Published

16/06/2020

How to Cite

GUEDES, B. L. C. dos S.; NASCIMENTO, A. K. P. do; MELO, B. T. G.; CUNHA, S. M. D. da; OLIVEIRA FILHO, A. A. de; OLIVEIRA, H. M. B. F. de. General aspects of COVID-19 in pregnant and newborn health: A brief review. Research, Society and Development, [S. l.], v. 9, n. 7, p. e897974969, 2020. DOI: 10.33448/rsd-v9i7.4969. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/4969. Acesso em: 20 apr. 2024.

Issue

Section

Review Article